At DNA Genotek, we are continually being introduced to new and exciting research projects through the innovative work of our customers. I recently came across a particularly interesting study which is known as one of the largest metastatic breast cancer studies to date. The study, led by the Broad Institute of MIT and Harvard University, is called the Metastatic Breast Cancer (MBC) Project. This project caught my attention because of their unique approach to patient recruitment and engagement which is garnering media coverage across the country.Read More
DNA Genotek's Sample Collection Blog
There are few subjects that have received as much coverage in the genetics space in recent months as precision medicine. The conversation about precision medicine began many years ago but the recent launch of the Precision Medicine Initiative in the United States and similar projects in many other countries around the world has brought this topic to the main stream. There remain many questions about the implementation of precision medicine with people looking to doctors and clinicians as the first and most obvious choice as the point of contact for patients. However, one group in British Columbia, Canada is looking to local community pharmacists to bring precision medicine closer to those who can benefit most.Read More
A year or so ago, Nature Communications published an article that highlighted how researchers in the Department of Genetics at the University of Leicester successfully used DNA from saliva to help identify the remains of King Richard III and solved a 500 year old mystery. The story behind the recovery of the remains and their subsequent identification as those of the missing king is an interesting one that combines ancient DNA analysis with modern DNA from saliva.Read More
Front Line Genomics is a new company with a mission to help bring the benefits of genomics to patients faster. DNA Genotek interviewed Richard Lumb, CEO of Front Line Genomics about the company, its social mission and their upcoming Festival of Genomics in Boston.Read More
In the summer of 2011 we wrote about an exciting project out of the United Kingdom that selected Oragene collection kits for a study that aimed to unlock genetic changes behind development disorders. The Deciphering Developmental Disorders (DDD) study is a direct collaboration with all twenty-three of the NHS Clinical Genetics Services from across the UK together with the Wellcome Trust Sanger Institute.
Everyone at DNA Genotek is familiar with event-based collections. We’ve worked with dozens of customers over the years to help facilitate collecting samples for breast cancer, epilepsy, HLA-typing and more. Recently, our products were used in an event-based collection to support education and provide information on how genes are linked to our ancestry. The New Horizons Festival (NHF) was held at Erasmus MC and several other public locations in Rotterdam, the Netherlands on September 26, 2014 and over 1,500 people participated. The purpose of the event was to make science accessible and attractive to the general public by merging science with art and music to create a fun, interactive event.
In a recent article on The Genetic Link, we talked about going global and how our regulatory strategy helps support our customers who are conducting genetic research. Today, I am focusing on the work we do to ensure our products' compatibility with the technologies our genetic research and testing customers use in the field and in their labs.
Obtaining DNA samples in sufficient numbers and in a timely manner can be a barrier to achieving statistical relevance for research studies. Maximizing recruitment means making sample collection easy and convenient for donors. Recently the Basser Research Center for BRCA at the University of Pennsylvania successfully used event-based collection to rapidly grow the number of participants in their research project.
Since the launch of The Genetic Link blog back in 2009, we’ve shared dozens of stories from the field highlighting remote DNA collections, innovative approaches to research, and unique event-based collections. Each of these stories was based on a research team searching for the gene or genes responsible for a particular disease or health condition. The story in this article is unique in that it highlights a project that is hoping to attract individuals who are willing to share their personal genome, health information and trait data for a broader application. The goal is to advance scientific progress by inviting willing participants to share their personal genetic data for the greater good.
DNA Genotek is a recognized leader in the biostabilization technology field and today, we received a new honor for our work in this area. Our HEMAgene™•BUFFY COAT stabilizing reagent received the 2014 Outstanding Product Award from the International Society for Biological and Environmental Repositories (ISBER) at their annual meeting in Orlando, Florida, USA. The ISBER Annual Meeting is widely recognized as the premier event in the field of repository and specimen management.